4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000950170-23-007570
Chief Executive Officer bought 5,500 shares at $29.15 ($160,324)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Myers Scott Dunseth Chief Executive Officer | 2023-03-13 | Purchase | +5,500 | $29.15 | $160,324 | 255,500 | D |
| Open-market purchases · 5,500 sh · avg $29.15 · $160,324 | |||||||
Loading xslF345X03/ownership.xml…